Company Search:
Advanced Search
Sponsored Links
Dr. Lal PathLabs Ltd Company Snapshot
Dr. Lal PathLabs Ltd operates in the Medical laboratories sector. In addition to historical fundamental analyses, the complete report available to purchase compares Dr. Lal PathLabs Ltd with three other pharmaceutical manufacturers in Asia: Thyrocare Technologies Ltd (2019 sales of 4.03 billion Indian Rupees [US$56.37 million] of which 91% was Diagnostic Testing Services), Malaysian Genomics Resource Centre Berhad of Malaysia (27.73 million Malaysian Ringgits [US$6.63 million] ), and Medical & Biological Laboratories Company Limited which is based in Japan (8.18 billion Japanese Yen [US$75.69 million] of which 99% was Reagent business).

Sales Analysis. Dr. Lal PathLabs Ltd reported sales of 12.03 billion Indian Rupees (US$168.36 million) for the fiscal year ending March of 2019. This represents an increase of 13.9% versus 2018, when the company's sales were 10.57 billion Indian Rupees. Sales at Dr. Lal PathLabs Ltd have increased during each of the previous five years (and since 2014, sales have increased a total of 116%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Dr. Lal PathLabs Ltd
  Stock Performance Chart for Dr. Lal PathLabs Ltd
  Stock Data: Recent Stock Performance:
  Current Price (9/20/2019): 1,316.85
(Figures in Indian Rupees)
1 Week -0.6%   13 Weeks 15.1%  
4 Weeks 13.3%   52 Weeks 40.9%  
Dr. Lal PathLabs Ltd Key Data:
  Ticker: LALPATHLAB Country: India
  Exchanges: BOM Major Industry: Health Care Equipment & Services
    Sub Industry: Medical Laboratories
  2019 Sales 12,034,180,000
(Year Ending Jan 2020).
Employees: 4,190
  Currency: Indian Rupees Market Cap: 108,430,466,678
  Fiscal Yr Ends: March Shares Outstanding: 82,340,788
  Share Type: Ordinary Closely Held Shares: 57,567,710
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.